

![]() |
Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience |
|
Authors | ||
Published in | International Journal of Radiation Oncology, Biology, Physics. 2004, vol. 58, no. 5, p. 1431-6 | |
Abstract | Accelerated schedules are effective in overcoming repopulation during radiotherapy (RT) for head-and-neck cancers, but their feasibility is compromised by increased toxicity. The therapeutic ratio may be particularly favorable for 5-week regimens. This study reports the 10-year experience of a single institution in the routine use of concomitant boost RT as standard radical treatment in all but the most favorable stage patients. | |
Keywords | Adolescent — Adult — Aged — Aged, 80 and over — Antineoplastic Combined Chemotherapy Protocols/therapeutic use — Carcinoma, Squamous Cell/drug therapy/radiotherapy/surgery — Cause of Death — Cisplatin/administration & dosage — Combined Modality Therapy — Dose Fractionation — Feasibility Studies — Female — Fluorouracil/administration & dosage — Head and Neck Neoplasms/drug therapy/radiotherapy/surgery — Humans — Male — Middle Aged — Statistics as Topic | |
Identifiers | PMID: 15050320 | |
Full text | ||
Structures | ||
Research group | Groupe Dulguerov Pavel (ORL et chirurgie cervico-faciale) (145) | |
Citation (ISO format) | ALLAL, Abdelkarim Said et al. Can concomitant-boost accelerated radiotherapy be adopted as routine treatment for head-and-neck cancers? A 10-year single-institution experience. In: International Journal of Radiation Oncology, Biology, Physics, 2004, vol. 58, n° 5, p. 1431-6. doi: 10.1016/j.ijrobp.2003.09.017 https://archive-ouverte.unige.ch/unige:33112 |